Epidemiology of candidemia in intensive care units.

[1]  Jianping Xu,et al.  Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Y. Carmeli,et al.  Risk factors for albicans and non-albicans candidemia in the intensive care unit* , 2008, Critical care medicine.

[3]  E. Bouza,et al.  Bloodstream Infections: Evolution and Trends in the Microbiology Workload, Incidence, and Etiology, 1985-2006 , 2008, Medicine.

[4]  Y. Carmeli,et al.  Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  B. Arthington-Skaggs,et al.  Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[6]  R. Ryan,et al.  Vertical and Horizontal Transmission of Candida albicans in Very Low Birth Weight Infants Using DNA Fingerprinting Techniques , 2008, The Pediatric infectious disease journal.

[7]  M. Falagas,et al.  Candida Albicans Versus Non-Albicans Intensive Care Unit-Acquired Bloodstream Infections: Differences in Risk Factors and Outcome , 2008, Anesthesia and analgesia.

[8]  P. Hsueh,et al.  Candida glabrata fungaemia in intensive care units. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  C. d’Enfert,et al.  Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome , 2008, Intensive Care Medicine.

[10]  A. Chakrabarti,et al.  Candida colonization and candidemia in a pediatric intensive care unit , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[11]  Norma Fernández,et al.  Brote de candidemia por Candida albicans en neonatología , 2007 .

[12]  N. Kartsonis,et al.  Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial. , 2007, Journal of critical care.

[13]  E. Roilides,et al.  Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome , 2007, Intensive Care Medicine.

[14]  J. Vazquez,et al.  Epidemiology, Risk Factors, and Outcomes of Candida albicans Versus Non-albicans Candidemia in Nonneutropenic Patients , 2007, The Annals of pharmacotherapy.

[15]  M. Kollef,et al.  Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia , 2007, Critical care medicine.

[16]  P. Smith,et al.  Excess Costs of Hospital Care Associated With Neonatal Candidemia , 2007, The Pediatric infectious disease journal.

[17]  X. S. Passos,et al.  Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital , 2007, Mycopathologia.

[18]  B. Alexander,et al.  Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  V. Blanc,et al.  Épidémiologie des fongémies dans les hôpitaux français non universitaires en 2004 : enquête multicentrique ColBVH , 2006 .

[20]  P. Lipsett,et al.  The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. , 2006, Diagnostic microbiology and infectious disease.

[21]  A. Muriel,et al.  Risk Factors for Candidemia in Pediatric Patients With Congenital Heart Disease , 2006, Infection Control & Hospital Epidemiology.

[22]  D. Kaufman,et al.  Changing Incidence of Candida Bloodstream Infections Among NICU Patients in the United States: 1995–2004 , 2006, Pediatrics.

[23]  Benjamin J Park,et al.  Candidemia in Neonatal Intensive Care Units: Barcelona, Spain , 2006, The Pediatric infectious disease journal.

[24]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[25]  M. Bassetti,et al.  Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.

[26]  S. Fridkin,et al.  Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 , 2005, Journal of Clinical Microbiology.

[27]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  P. Olaechea,et al.  Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[29]  W. Gransden,et al.  Candidaemia in a London teaching hospital: analysis of 128 cases over a 7‐year period , 2003, Mycoses.

[30]  V. Anttila,et al.  Candidemia in Finland, 1995–1999 , 2003, Emerging infectious diseases.

[31]  L. Bonavina,et al.  Candida colonization in patients with esophageal disease: a prospective clinical study. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[32]  R. Gaynes,et al.  Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  L. R. Ásmundsdóttir,et al.  Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland , 2002, Journal of Clinical Microbiology.

[34]  H. Richet,et al.  Candidemia in French hospitals: incidence rates and characteristics. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[35]  M. Pfaller,et al.  Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study , 2002, Journal of Clinical Microbiology.

[36]  E. Anaissie,et al.  Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  L. Saiman,et al.  Risk factors for Candida species colonization of neonatal intensive care unit patients. , 2001, The Pediatric infectious disease journal.

[38]  L. Saiman,et al.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[40]  R. Pinner,et al.  The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  E. Bouza,et al.  Report of ESGNI–001 and ESGNI–002 studies. Bloodstream infections in Europe , 1999 .

[43]  M. Halpern,et al.  The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  Ronald N. Jones,et al.  National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. , 1998, Diagnostic microbiology and infectious disease.

[45]  R. Woolson,et al.  Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.

[46]  V. Blanc,et al.  [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004]. , 2006, Pathologie-biologie.

[47]  A. Sitges-Serra,et al.  Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy , 1997, Intensive Care Medicine.